Deutsche Bank
CUE icon

Deutsche Bank’s Cue Biopharma CUE Stock Holding History

Deutsche Bank’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-993
Closed -$56.3K – 3591
2024
Q1 		$56.3K Hold
993
– – ﹤0.01% 3367
2023
Q4 		$78.7K Buy
993
+915
+1,173% +$65.4K ﹤0.01% 3326
2023
Q3 		$5.4K Buy
+78
New +$7.62K ﹤0.01% 3600
2022
Q2 		– Sell
-743
Closed -$108K – 4162
2022
Q1 		$108K Sell
743
-38
-5% -$8.06K ﹤0.01% 3553
2021
Q4 		$265K Buy
781
+20
+3% +$7.73K ﹤0.01% 3223
2021
Q3 		$333K Sell
761
-297
-28% -$104K ﹤0.01% 3282
2021
Q2 		$370K Buy
1,058
+108
+11% +$41.9K ﹤0.01% 3418
2021
Q1 		$348K Sell
950
-305
-24% -$126K ﹤0.01% 3326
2020
Q4 		$471K Buy
1,255
+447
+55% +$179K ﹤0.01% 2946
2020
Q3 		$365K Buy
808
+207
+34% +$119K ﹤0.01% 2832
2020
Q2 		$442K Buy
601
+362
+151% +$262K ﹤0.01% 2713
2020
Q1 		$102K Sell
239
-2
-0.8% -$970 ﹤0.01% 3241
2019
Q4 		$114K Buy
241
+49
+26% +$15.4K ﹤0.01% 3521
2019
Q3 		$46K Sell
192
-268
-58% -$64.4K ﹤0.01% 3974
2019
Q2 		$123K Sell
460
-301
-40% -$74.8K ﹤0.01% 4101
2019
Q1 		$175K Sell
761
-9
-1% -$1.71K ﹤0.01% 4072
2018
Q4 		$107K Sell
770
-568
-42% -$103K ﹤0.01% 4192
2018
Q3 		$364K Buy
1,338
+209
+19% +$60.4K ﹤0.01% 3946
2018
Q2 		$402K Buy
1,129
+748
+196% +$297K ﹤0.01% 3961
2018
Q1 		$159K Buy
+381
New +$174K ﹤0.01% 4307

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Deutsche Bank's CUE Position: Q2 2024 in Review

Deutsche Bank sold out of Cue Biopharma (CUE) in Q2 2024, closing a stake of 993 shares — an estimated $56.3K sold.

Deutsche Bank first reported a position in CUE in Q1 2018 and held it in 20 quarters. The position peaked at $471K in Q4 2020. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2024.

  • Deutsche Bank reported no remaining Cue Biopharma position as of Q2 2024 after selling out during the quarter.
  • Deutsche Bank sold 993 Cue Biopharma shares in Q2 2024, an estimated $56.3K.
  • Deutsche Bank first reported a position in Cue Biopharma in Q1 2018 and held it in 20 quarters.
  • Deutsche Bank's Cue Biopharma position peaked at $471K in Q4 2020.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.